C J McDougle

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. ncbi A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
    C J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis 46202 5200, USA
    Arch Gen Psychiatry 55:633-41. 1998
  2. ncbi A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
    C J McDougle
    Department of Psychiatry, Section of Child and Adolescent Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202 5200, USA
    Arch Gen Psychiatry 57:794-801. 2000
  3. ncbi Limited efficacy of ketoconazole in treatment-refractory major depression
    R T Malison
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Clin Psychopharmacol 19:466-70. 1999
  4. ncbi Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors
    C J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, USA
    J Autism Dev Disord 30:427-35. 2000
  5. ncbi A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders
    D J Posey
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, USA
    J Child Adolesc Psychopharmacol 11:267-77. 2001
  6. ncbi Possible role of neuropeptides in obsessive compulsive disorder
    C J McDougle
    Indiana University School of Medicine, Department of Psychiatry, Indianapolis 46202, USA
    Psychoneuroendocrinology 24:1-24. 1999
  7. ncbi Pharmacotherapeutic management of autism
    D J Posey
    Department of Psychiatry, Indaiana University School of Medicine, USA
    Expert Opin Pharmacother 2:587-600. 2001
  8. ncbi The pathophysiology and treatment of autism
    D J Posey
    Department of Psychiatry, Indiana University School of Medicine, 541 Clinical Drive, Indianapolis, IN 46202, USA
    Curr Psychiatry Rep 3:101-8. 2001
  9. ncbi Trichotillomania. Presentation, etiology, diagnosis and therapy
    K H Walsh
    Indiana University School of Medicine, Indianapolis, Indiana, USA
    Am J Clin Dermatol 2:327-33. 2001

Collaborators

Detail Information

Publications9

  1. ncbi A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
    C J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis 46202 5200, USA
    Arch Gen Psychiatry 55:633-41. 1998
    ..Open-label reports suggest that the serotonin2A-dopamine D2 antagonist risperidone may be safe and effective in reducing the interfering symptoms of patients with autism...
  2. ncbi A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
    C J McDougle
    Department of Psychiatry, Section of Child and Adolescent Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202 5200, USA
    Arch Gen Psychiatry 57:794-801. 2000
    ..This report describes the first controlled study of risperidone addition in patients with OCD refractory to treatment with SRI alone...
  3. ncbi Limited efficacy of ketoconazole in treatment-refractory major depression
    R T Malison
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Clin Psychopharmacol 19:466-70. 1999
    ..These findings suggest a limited efficacy for ketoconazole in patients with treatment-refractory major depression...
  4. ncbi Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors
    C J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, USA
    J Autism Dev Disord 30:427-35. 2000
    ..One controlled study of the selective SRI fluvoxamine found it to be significantly better than placebo for reducing repetitive phenomena and aggression in adults with autistic disorder. Additional research is needed...
  5. ncbi A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders
    D J Posey
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, USA
    J Child Adolesc Psychopharmacol 11:267-77. 2001
    ..CONCLUSIONS: Mirtazapine was well tolerated but showed only modest effectiveness for treating the associated symptoms of autistic disorder and other PDDs...
  6. ncbi Possible role of neuropeptides in obsessive compulsive disorder
    C J McDougle
    Indiana University School of Medicine, Department of Psychiatry, Indianapolis 46202, USA
    Psychoneuroendocrinology 24:1-24. 1999
    ....
  7. ncbi Pharmacotherapeutic management of autism
    D J Posey
    Department of Psychiatry, Indaiana University School of Medicine, USA
    Expert Opin Pharmacother 2:587-600. 2001
    ..Current pharmacological management is best aimed at target symptoms that have been demonstrated to respond to medication in treatment studies...
  8. ncbi The pathophysiology and treatment of autism
    D J Posey
    Department of Psychiatry, Indiana University School of Medicine, 541 Clinical Drive, Indianapolis, IN 46202, USA
    Curr Psychiatry Rep 3:101-8. 2001
    ..Significant gains have been made in determining which pharmacologic treatments are efficacious in autism. Additional research is needed on agents that might ameliorate the core and associated symptoms of autism...
  9. ncbi Trichotillomania. Presentation, etiology, diagnosis and therapy
    K H Walsh
    Indiana University School of Medicine, Indianapolis, Indiana, USA
    Am J Clin Dermatol 2:327-33. 2001
    ..Specialized psychotherapy, known as habit reversal training, is highly recommended; however, the treatment is intensive and highly specialized. Skilled therapists are difficult to locate...